Skip to content

A multicenter, randomized, open, parallel-controlled trial of lengthening depth of field intraocular lens for visual acuity correction after cataract extraction

A multicenter, randomized, open, parallel-controlled trial of lengthening depth of field intraocular lens for visual acuity correction after cataract extraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079028
Enrollment
Unknown
Registered
2023-12-24
Start date
2023-12-24
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

trial group:Implanting Large focal depth intraocular lens (extended depth of field type)
control:Implanting control group crystals

Sponsors

XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY; Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 81 Years

Inclusion criteria

Inclusion criteria: 1. Age = 2.00 mm; 5. Postoperative predicted corneal astigmatism <= 1.5D; 6. The expected intraocular lens refraction was between +5.0D and +30.0D; 7. Patients who were able to complete 6-month follow-up; 8. Be able to understand the purpose of the trial, voluntarily participate in the clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women, and those who plan to become pregnant within 6 months after the operation; 2. The best corrected distal visual acuity > 20/40 (LogMAR visual acuity chart); 3. Preoperative corneal endothelial cell count 8 mmol/L), or a history of diabetes associated with eye diseases or conditions affecting postoperative vision; 19. Electrocardiogram or laboratory examination results indicate contraindications to surgery; 20. Unsupervised or unable to follow medical advice; 21. Other conditions that the investigator judged unsuitable for participation in the experiment.

Design outcomes

Primary

MeasureTime frame
At 6 months after surgery, optimal corrected distal vision;At 6 months after surgery, median vision under optimal corrected far vision;

Secondary

MeasureTime frame
Best corrected far vision;

Countries

China

Contacts

Public ContactXiaopo Xia/ Tian Fang

XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY; Tianjin Medical University Eye Hospital

xbxia21@163.com+86 158 7489 8016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026